JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB196020

Anti-Nkx3.1 antibody [EPR16653]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal Nkx3.1 antibody. Suitable for WB, IHC-P, mIHC and reacts with Human samples. Cited in 8 publications.

View Alternative Names

NKX3.1, NKX3A, NKX3-1, Homeobox protein Nkx-3.1, Homeobox protein NK-3 homolog A

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nkx3.1 antibody [EPR16653] (AB196020)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nkx3.1 antibody [EPR16653] (AB196020)

Immunohistochemical analysis of paraffin-embedded Human prostate hyperplasia tissue labeling Nkx3.1 with ab196020 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nuclear staining on Human prostate hyperplasia tissue is observed. Counter stained with Hematoxylin.

Negative control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nkx3.1 antibody [EPR16653] (AB196020)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nkx3.1 antibody [EPR16653] (AB196020)

Immunohistochemical analysis of paraffin-embedded Human testis tissue labeling Nkx3.1 with ab196020 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Human testis tissue acting as a negative control for Nkx3.1. Counter stained with Hematoxylin.

Negative control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Multiplex immunohistochemistry - Anti-Nkx3.1 antibody [EPR16653] (AB196020)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-Nkx3.1 antibody [EPR16653] (AB196020)

Fluorescence multiplex immunohistochemical analysis of human prostate gland tissue (formalin/PFA-fixed paraffin-embedded section). Panel A : merged staining of anti-Prostate Specific Antigen (ab76113, red; Opal™690), anti-Cytokeratin 5 (ab236216, green; Opal™520) and anti-Nkx3.1 (ab196020, gray; Opal™570) on human prostate gland tissue. Panel B : anti-Prostate Specific Antigen stained on cytoplasm of luminal cells. Panel C : anti-Cytokeratin 5 stained on basal cells. Panel D : anti-p63 stained on nucleus of luminal cells. Opal Polymer HRP Ms + Rb was used as a secondary antibody. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. The section was incubated in three rounds of staining : in the order of ab76113 (1/2000), ab236216 (1/400) and ab196020 (1/2000) for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. Each round was followed by a separate fluorescent tyramide signal amplification system. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) was used for 20 mins. DAPI (blue) was used as a nuclear counter stain. Image acquisition was performed with Leica SP8 confocal microscope.

Western blot - Anti-Nkx3.1 antibody [EPR16653] (AB196020)
  • WB

Supplier Data

Western blot - Anti-Nkx3.1 antibody [EPR16653] (AB196020)

Blocking/Dilution buffer : 5% NFDM/TBST.

Lane 2, PC-3 (Human prostate cancer cell line) is acting as a negative control for Nkx3.1. The 32kDa band may represent the glycosylated form.

All lanes:

Western blot - Anti-Nkx3.1 antibody [EPR16653] (ab196020) at 1/1000 dilution

Lane 1:

LNCaP (Human prostate cancer cell line) cell lysate at 10 µg

Lane 2:

PC-3 (Human prostate cancer cell line) cell lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 32 kDa

false

Exposure time: 3min

Western blot - Anti-Nkx3.1 antibody [EPR16653] (AB196020)
  • WB

Supplier Data

Western blot - Anti-Nkx3.1 antibody [EPR16653] (AB196020)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Nkx3.1 antibody [EPR16653] (ab196020) at 1/1000 dilution

All lanes:

Human prostate lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 32 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-Nkx3.1 antibody [EPR16653] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR16653

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

mIHC, IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>", "mIHC-species-checked": "testedAndGuaranteed", "mIHC-species-dilution-info": "1/2000", "mIHC-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nkx3.1 known also as NK-3 transcription factor related locus 1 is a protein that acts as a transcription factor. Its molecular mass is approximately 25 kDa. The expression of Nkx3.1 occurs mostly in the prostate but you can also see it in other tissues like testis and certain brain regions. It plays roles in androgen receptor signaling where it binds to specific DNA sequences to regulate the transcription of target genes influencing cell growth and differentiation.
Biological function summary

Nkx3.1 is involved in regulating prostate epithelial cell differentiation and maintaining proper glandular architecture. It does not appear to form part of a larger protein complex but instead interacts directly with DNA to control gene expression. Alongside this it may involve co-regulatory proteins to execute its transcriptional activities effectively controlling the expression of genes critical for normal prostate function.

Pathways

Nkx3.1 is involved in the prostate cancer pathway and the androgen receptor signaling pathway. Within these pathways its interactions include those with proteins such as the androgen receptor (AR) and the homeobox protein Nkx2-5 coordinating the cellular responses to hormonal signals. These interactions allow Nkx3.1 to modulate the transcription of genes responsive to androgens which impacts cellular proliferation and development within prostate tissues.

Alterations in the Nkx3.1 protein function relate most notably to prostate cancer and benign prostatic hyperplasia (BPH). Loss or mutation of the Nkx3.1 gene often coincides with early stages of prostate cancer development. Through the androgen receptor pathway Nkx3.1 influences disease progression where decreased expression or activity can exacerbate cellular abnormalities. Understanding its altered interactions in these diseases particularly with the androgen receptor provides insight into mechanisms driving prostate disorders offering potential targets for therapeutic intervention.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells.
See full target information NKX3-1

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1609340 PubMed40873563

2025

Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoshi Ma,Kun Chen,Jing Zhang,Liming Liu,Jiping Luo,Kaipeng Huang,Hongying Zhang,Danni Liu,Jizhou Gou,Changyin Feng,Xia Zhao,Wanying Li,Lipeng Chen,Li Yin,Xianlin Meng,Zhiqiang Cheng

Cancer cell international 25:226 PubMed40544244

2025

Prognostic and therapeutic potential of disulfidptosis-related genes in colon adenocarcinoma: a comprehensive multi-omics study.

Applications

Unspecified application

Species

Unspecified reactive species

Ye Song,Haoran Zhu,Junyang Wei,Shanxue Yin

Journal of hepatocellular carcinoma 11:879-900 PubMed38770169

2024

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Liqun Peng,Shaohua Xu,Jian-Liang Xu

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2305724 PubMed38483933

2024

Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaojie Bian,Wenfeng Wang,Mierxiati Abudurexiti,Xingming Zhang,Weiwei Ma,Guohai Shi,Leilei Du,Midie Xu,Xin Wang,Cong Tan,Hui Sun,Xiadi He,Chenyue Zhang,Yao Zhu,Min Zhang,Dingwei Ye,Jianhua Wang

Cell & bioscience 13:39 PubMed36823643

2023

TPM2 attenuates progression of prostate cancer by blocking PDLIM7-mediated nuclear translocation of YAP1.

Applications

Unspecified application

Species

Unspecified reactive species

Zonglong Wu,Liyuan Ge,Lulin Ma,Min Lu,Yimeng Song,Shaohui Deng,Peichen Duan,Tan Du,Yaqian Wu,Zhanyi Zhang,Shudong Zhang

Cell death & disease 13:624 PubMed35853880

2022

Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression.

Applications

Unspecified application

Species

Unspecified reactive species

Tianqi Wu,Wenfeng Wang,Guohai Shi,Mingang Hao,Yingying Wang,Mengfei Yao,Yongqiang Huang,Leilei Du,Xingming Zhang,Dingwei Ye,Xiaojie Bian,Jianhua Wang

Oncology letters 24:258 PubMed35765275

2022

KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Anyu Luo,Hanlin Liu,Chen Huang

Cancer discovery 10:1038-1057 PubMed32376773

2020

Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Josef Leibold,Marcus Ruscetti,Zhen Cao,Yu-Jui Ho,Timour Baslan,Min Zou,Wassim Abida,Judith Feucht,Teng Han,Francisco M Barriga,Kaloyan M Tsanov,Leah Zamechek,Amanda Kulick,Corina Amor,Sha Tian,Katarzyna Rybczyk,Nelson R Salgado,Francisco J Sánchez-Rivera,Philip A Watson,Elisa de Stanchina,John E Wilkinson,Lukas E Dow,Cory Abate-Shen,Charles L Sawyers,Scott W Lowe
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com